Analysis: GSK bolsters medicine chest with biotechnology buy

Analysis Gsk Bolsters Medicine Chest Biotechnology - Psychology, Special Needs, Health - Posted: 18th Jul, 2012 - 12:30am

Text RPG Play Text RPG ?
 

Posts: 1 - Views: 307
Reply Add Reply
Biotechnology News
Post Date: 18th Jul, 2012 - 12:30am / Post ID: #

Avatar
NOTE: Informer [?]

Analysis: GSK bolsters medicine chest with biotechnology buy

Analysis: GSK bolsters medicine chest with biotechnology buy
Biotechnology News

LONDON (Reuters) - GlaxoSmithKline chief executive Andrew Witty has an eye for a bargain. Despite paying a 99 percent premium for Human Genome Sciences, he is still getting the biotechnology company for less than half what it was worth 14 months ago. In exchange for his $3 billion cheque, which GSK can pay out of existing cash resources, Witty gets full control of a clutch of new medicines finally starting to flow from the decoding of human DNA. ...

Source: BioTech News Headlines - Yahoo! News

Sponsored Links:
Post Date: Wed Dec 18 15:14:04 GMT 2024 / Post ID: #

Avatar

Analysis: GSK bolsters medicine chest with biotechnology buy

Add Comment
Can someone tell me more about analysis: gsk bolsters medicine chest with biotechnology buy needs more feedback in a swift way to and know so I can decide for myself.



Comment Add Comment As A Guest
 
> TOPIC: Analysis: GSK bolsters medicine chest with biotechnology buy
« Next Oldest | Psychology, Special Needs & Health | Next Newest »
 

▲ TOP


International Discussions Coded by: BGID®
ALL RIGHTS RESERVED Copyright © 1999-2024
Disclaimer Privacy Report Errors Credits
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in our Cookies used here: Privacy / Disclaimer,